Form 4: Amgen Executive Reports Stock Disposition

Amgen EVP and General Counsel Jonathan P. Graham reported the disposition of 1,257 shares of common stock to cover tax obligations.

Summary

• Jonathan P. Graham, EVP & General Counsel of Amgen Inc., disposed of 1,257 shares of common stock on May 2, 2026.
• The transaction consisted of two separate disposals of 647 shares and 610 shares.
• The shares were disposed of at a price of $329.82 per share.
• The transaction was executed to satisfy tax withholding obligations related to the vesting of equity awards.
• Following these transactions, the reporting person maintains a beneficial ownership of 38,010 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax obligations rather than a strategic shift or market-driven sale.

Positives

• The transaction is a routine administrative action related to tax withholding upon the vesting of equity awards, rather than a discretionary sale of shares.

Negatives

• Reduction in the direct share ownership of a key executive.

Risks

• None identified; this is a standard regulatory filing for executive compensation tax compliance.

Future Outlook

Not applicable; this is a historical record of an insider transaction.

Industry Context

StockSavvy.ai notes that Form 4 filings regarding tax withholding are standard industry practice for biotechnology executives and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction aligns with standard corporate governance practices for large-cap pharmaceutical companies like Pfizer, Merck, and Gilead, where executives frequently settle tax obligations via share withholding.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a standard tax-related equity settlement.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Amgen, AMGN, Form 4, Insider Trading, Executive Compensation, Stock Disposition